Yesterday, the Food and Drug Administration revoked emergency authorization for the malaria drug promoted by President Trump, hydroxychloroquine, warning of serious side effects and increasing evidence that the treatment doesn’t work. The FDA also warned doctors against prescribing the drugs in combination with remdesivir, a drug currently shown to helpContinue Reading

The reopening of the world economy is largely reliant on easy and accessible COVID-19 screening. Kaligia Biosciences, a medical device company, is working with major Florida medical institutions to develop a portable, saliva-based device that can produce results in less than three minutes. Kaligia Biosciences is starting clinical trials of theContinue Reading